Thu, Jul 31, 2014, 12:47 PM EDT - U.S. Markets close in 3 hrs 13 mins


% | $
Click the to save as a favorite.

Advanced Cell Technology Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • mclarence89 mclarence89 Aug 4, 2010 12:17 PM Flag

    Large Drug Companies and ACTC

    I find that interesting. You would rather have $2.00 than maybe $10.00 to 20.00 in 3 or 4 years? Thanks for an honest answer.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • As Biosect keeps reminding people, the simple PPS --- alone --- is not as good an indicator of a company's worth...

      It's the MARKET CAP that most people judge a ocmpany by....

      If ACTC were only 5M or 15M, its PPS would be at least a few dollars already, so the PPS again is not that good of an indication of a company pre-clinical, clinical, or intellectual proprietary worth....

      Given that SMD and AMD both --- and other related vision problems --- MAY BE TACKLED by cellular reprogramming work... IF SUCCESSSFUL, if SMD is successful, that is.... AMD is just a GIANT of a market, with BILLIONS of older and elderlies who have lost vision, due to aging... but who, given a chance, would want their eye sight to work well...

      AMD and related vision programs COULD BE EXTREMELY LUCRATIVE... so, again, if SMD (the smaller, orphan progam) works, and we should know well enough to judge within JUST ONE YEAR, at most... if SMD works... Advanced Cell's MARKET CAP can be, initially, $1-$3B easily.

      The trick, in these highly competitive fields, is to be the FIRST in the field.... although everyone can try, if you are ahead and the FDA gives you the go ahead on human trial on a certain program, you are at least a year, or two, or three ahead of the crowds, since each and eveyrone of them MUST go through very similar and TEDIOUS work like you do, to get an initial OK to start what you've already started on, etc., etc....

      So ACTC really DOES have an edge on using hESCs in VISION LOSS problems.

      If it is able to make vision loss into a successful field of medical pursuit, ACTC doesn't have to do much else, to be a multi-billion dollar small to mid cap company.....

    • You would rather have $2.00 than maybe $10.00 to 20.00 in 3 or 4 years?

      With this many shares outstanding??? OK.

0.068+0.003(+3.82%)12:30 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.